Avalon Globocare CorpNASDAQ:ALBT
- LAST PRICE2.4900
- TODAY'S CHANGE (%)-0.1600 (-6.0377%)
- Bid / Lots2.4200/ 1
- Ask / Lots2.7700/ 1
- Open / Previous Close2.6500 / 2.6500
- Day Range
- 52 Week Range
- Volume54,798
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ALBT |
|---|---|---|
| 09:32 ET | 600 | 2.65 |
| 09:33 ET | 135 | 2.661 |
| 09:39 ET | 100 | 2.59 |
| 09:44 ET | 250 | 2.625 |
| 09:57 ET | 270 | 2.6683 |
| 10:00 ET | 1200 | 2.65 |
| 10:06 ET | 500 | 2.645 |
| 10:15 ET | 500 | 2.6 |
| 10:27 ET | 891 | 2.65 |
| 10:31 ET | 2470 | 2.67 |
| 10:33 ET | 13875 | 2.65 |
| 10:36 ET | 1249 | 2.66 |
| 10:38 ET | 300 | 2.65 |
| 10:40 ET | 200 | 2.65 |
| 10:42 ET | 2301 | 2.62 |
| 10:44 ET | 2583 | 2.62 |
| 10:47 ET | 500 | 2.672 |
| 11:02 ET | 400 | 2.57 |
| 11:14 ET | 100 | 2.58 |
| 11:45 ET | 1800 | 2.55 |
| 11:48 ET | 1626 | 2.5 |
| 11:52 ET | 153 | 2.575 |
| 12:12 ET | 400 | 2.52 |
| 12:14 ET | 100 | 2.6144 |
| 12:15 ET | 100 | 2.63 |
| 12:39 ET | 200 | 2.58 |
| 12:46 ET | 100 | 2.54 |
| 12:50 ET | 2069 | 2.5 |
| 12:51 ET | 1697 | 2.5 |
| 01:08 ET | 600 | 2.4601 |
| 01:15 ET | 100 | 2.4833 |
| 01:22 ET | 299 | 2.44 |
| 01:26 ET | 199 | 2.44 |
| 01:31 ET | 1298 | 2.43 |
| 01:54 ET | 449 | 2.44 |
| 01:56 ET | 100 | 2.44 |
| 02:00 ET | 348 | 2.45 |
| 02:05 ET | 600 | 2.47 |
| 02:18 ET | 100 | 2.46 |
| 02:21 ET | 195 | 2.46 |
| 02:23 ET | 398 | 2.4549 |
| 02:41 ET | 100 | 2.44 |
| 02:43 ET | 185 | 2.44 |
| 02:56 ET | 481 | 2.43 |
| 02:57 ET | 271 | 2.41 |
| 02:59 ET | 400 | 2.4 |
| 03:17 ET | 500 | 2.411 |
| 03:24 ET | 189 | 2.455 |
| 03:42 ET | 1064 | 2.46 |
| 03:51 ET | 156 | 2.422 |
| 04:00 ET | 529 | 2.49 |
Yesterday
Avalon GloboCare Regains Compliance with Nasdaq Continued Listing Requirements, from 9:00AM ET on Thursday Nov 21, 2024 by Dow Jones
9:00AM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 18, 2024
Avalon GloboCare Launches "BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device, from 9:00AM ET on Monday Nov 18, 2024 by Dow Jones
9:00AM ET on Monday Nov 18, 2024 by Dow Jones
Oct 31, 2024
Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales, from 9:00AM ET on Thursday Oct 31, 2024 by Dow Jones
9:00AM ET on Thursday Oct 31, 2024 by Dow JonesPress Release: Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales, from 9:00AM ET on Thursday Oct 31, 2024 by Dow Jones
9:00AM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 25, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Avalon Globocare Corp | 2.8M | -0.1x | --- |
Mitesco Inc | 3.3M | -0.7x | --- |
PTS Inc | 1.9M | --- | --- |
IMAC Holdings Inc | 1.9M | -0.2x | --- |
Mainz Biomed NV | 4.6M | -0.2x | --- |
Genetic Technologies Ltd | 6.2M | -0.4x | --- |
Company Information
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. The Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.
Contact Information
- Headquarters
- 4400 ROUTE 9, SUITE 3100FREEHOLD, NJ, United States 07728
- Phone
- 732-780-4400
- Fax
- 732-780-5600
Executives
- Chairman of the Board of Directors
- Wenzhao Lu
- President, Chief Executive Officer, Director
- David Jin
- Chief Financial Officer
- Luisa Ingargiola
- Chief Operating Officer, Company Secretary
- Meng Li
- Director
- Wilbert Tauzin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.8M |
|---|---|
Revenue (TTM) | $1.3M |
Shares Outstanding | 1.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.27 |
EPS | $-19.56 |
Book Value | $10.05 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 2.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -971.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
